Newsby HottubFor agents

healio.com

FDA approves Sunharbo, factor XIa inhibitor for reducing stroke

The FDA has approved Sunharbo, the only approved factor XIa inhibitor intended to reduce the risk for stroke in adults who recently experienced a non-cardioembolic ischemic stroke or high-risk transient ischemic attack. With the approval, physicians now have a treatment option that can lower patient risk for secondary stroke, which can come with more severe outcomes than incident strokes, said Ashkan Shoamanesh, MD, senior scientist with the Population Health Research…

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.